registry – Page 30 – Communicable Diseases Research

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Research

Published on 2021-05-112022-10-29
Journal: JAMA Network Open [Category] COVID-19, SARS,

Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID

Research Article

Published on 2021-05-112022-10-28
Journal: PLoS ONE [Category] COVID-19, SARS,

Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic

Research

Published on 2021-05-032022-10-29
Journal: JAMA Network Open [Category] COVID-19, SARS,

[키워드] 95% CI adjusted adjusted odds ratio Admission age American Heart Association body mass index cardiovascular Care change changes in Characteristics characteristics of patient cohort study Comorbidities COVID-19 COVID-19 disease severity COVID-19 mortality COVID-19 pandemic death decrease diagnosis of COVID-19 died disease severity evaluate explain Factor finding glucocorticoid hospital Importance In-hospital In-hospital death in-hospital mortality rate intensive care Logistic regression measure mechanical ventilation mortality rate objective Odds ratio pandemic participant Patient patients patients hospitalized patients with COVID-19 Point pulmonary infiltrate registry Relevance remained Remdesivir Result retrospective cohort study selected setting Sex significantly lower supplemental oxygen the United State The United States trend vital signs with COVID-19 women
[DOI] 10.1001/jamanetworkopen.2021.8828 PMC 바로가기 [Article Type] Research

Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry

Article

Published on 2021-05-012022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Changes in pediatric trauma during COVID-19 stay-at-home epoch at a tertiary pediatric hospital

신종 코로나바이러스 감염증(코로나19) 3차 소아과 병원 재택 기간 동안 소아 외상의 변화

Review

Published on 2021-05-012022-09-11
Journal: Journal of pediatric surgery [Category] SARS, 치료기술,

[키워드] Abuse Admission Admissions age All-terrain vehicle Alter assault blunt Blunt trauma Burn burns change children coronavirus COVID-19 emergency department epoch equipment Falls Gender Healthcare professional healthcare professionals hospital Injury involved less level 1 morbidity morbidity and mortality Mortality motor vehicle neglect no difference occurred pattern pediatric Penetrating Primary outcome proportion registry Regulation reported secondary to self-harm severity significant decrease significant increase significantly lower Stressor Struck by sub-analysis trauma Trauma Center
[DOI] 10.1016/j.jpedsurg.2021.01.020 PMC 바로가기 [Article Type] Review

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

인도에서 중등도에서 중증의 COVID-19 관련 사이토카인 방출 증후군(COVINTOC) 환자에 대한 토실리주맙과 표준 치료 대 표준 치료: 공개, 다기관, 무작위 배정, 대조, 3상 시험

Clinical Trial

Published on 2021-05-012022-09-12
Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 진단,

[키워드] 1:1 Action acute respiratory distress adverse event adverse events analyses anti-IL-6 receptor antibody assigned baseline Block randomisation Cipla clinical country COVID-19 COVID-19 progression Cytokine release syndrome death decrease discharge education effective eight Evidence FIVE Follow-up grade 3 hospital India intensive care investigated mechanical ventilation medication Ministry of Health moderate modified intention-to-treat multicentre occurred one patient Open-label participant Patient patients died phase 3 trial positive SARS-CoV-2 PCR post-hoc Prevent primary endpoint progression Racial randomised randomised controlled trial Randomly randomly assigned patients receive recruited reduced Registered registry reported Roche routine Safety Serious Adverse Events Seven severe COVID-19 shown standard care standard care group supported syndrome the primary endpoint Tocilizumab Treatment Trial with COVID-19
[DOI] 10.1016/S2213-2600(21)00081-3 PMC 바로가기 [Article Type] Clinical Trial

Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial

무증상 및 경증 COVID-19 환자에 대한 nelfinavir의 효능 및 안전성: 다기관, 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-282022-09-10
Journal: Trials [Category] SARS, 임상, 치료기술,

[키워드] 1:1 Administered administration adverse event adverse events age all-cause mortality ALT Analysis anticipated Antigen antiviral efficacy AST Asymptomatic asymptomatic patients blinded blinded outcome assessment Blinding blood glucose body temperature both group both groups capture caused childbearing potential clearance clinical Clinical efficacy clinical examinations Clinical symptoms clinical trial clinical trials comparator Patients condition Consent contraceptive method Controlled clinical trial cough COVID-19 creatinine creatinine clearance dataset Day defervescence diabete diabetes diarrhea discretion dissemination distribution drug element enrolled enrolment evaluate event exclusion criteria exploratory Factor female patient Fever Frequency Glucose group hazard ratio Hemophiliac Hemorrhagic history HIV infection hospital hypersensitivity incidence incidence rate Inclusion inclusion and exclusion criteria inclusion criteria Infection Informed consent initial investigator investigator-initiated investigators Japan Japanese LAMP limit log-rank test male Mild mild COVID-19 patient Mild disease mixed-effects model multicenter Nasopharyngeal swab Negative conversion Negative PCR nelfinavir null hypothesis number objective Open-label outcome oxygen Oxygen administration p value parallel group parameter participant Patient patients with asymptomatic PCR PCR test Pneumonia power Pregnancy primary endpoint Primary outcome principal investigator Probability probability distribution protocol random randomization Randomized Randomized controlled trial Registered registry reported required respiratory tract rifampicin room air safety endpoint Saliva saliva samples Sample size SARS-CoV-2 SARS-CoV-2 vaccination secondary efficacy endpoint serious complication serum creatinine severity specimen Standard status study period Study protocol supplementary material survival survival function Symptom symptomatic symptomatic COVID-19 Symptomatic treatment the log-rank test Three times daily Treatment treatment for HIV treatment period Trial Trial registration two-sided Unsuitable Viral viral dynamics Viral load virus was determined website Withdrawal withdrawal of consent
[DOI] 10.1186/s13063-021-05282-w PMC 바로가기 [Article Type] Letter

Initial Findings From the North American COVID-19 Myocardial Infarction Registry

Observational Study

Published on 2021-04-272022-10-05
Journal: Journal of the American College of Cardiology [Category] SARS, 임상,

Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR)

Original article (CR)

Published on 2021-04-232022-10-28
Journal: Rheumatology Advances in Practice [Category] COVID-19,

Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry

Article

Published on 2021-04-232022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] Admission Admissions age all-cause mortality Analysis antirheumatic agents Autoimmune disease Autoimmune diseases Barthel Index Biological biological therapy Clinical characteristics Clinical course Comorbidity complications Corticosteroid COVID-19 death decrease diagnosed with COVID-19 disease disease-modifying anti-rheumatic drug Effects Factor female General population Glucocorticoids greater Habitual hospitalized patient ICU immune system diseases in-hospital complications increased risk information intensive care invasive involved mechanical ventilation Mortality multivariate logistic regression Non-invasive Older outcome outcomes Patient patients patients with COVID-19 Poor Primary outcome Prognosis readmission registry SARS-CoV-2 secondary outcome selected Spanish subsequent Treatment variables Weighting with COVID-19
[DOI] 10.3390/jcm10091844 PMC 바로가기 [Article Type] Article